Health Highlights: Dec. 10, 2021

Potent new antivirals may hold steady against Omicron. New antiviral pills developed by Merck and Pfizer are expected to remain effective against the mutation-heavy variant, because they interfere with the ability of the coronavirus to replicate itself rather than its ability to infect human cells, experts say. Read more
Hope from an mRNA-based vaccine against HIV. In animal studies, the same mRNA technology that brought the world COVID vaccines appears to help combat the virus that causes AIDS. Read more
World unprepared for the next pandemic. Despite the havoc and suffering meted out by SARS-CoV-2, nations around the globe still aren't prepared to prevent or deal with another pandemic because many aren't taking the necessary measures, according to this year's Global Health Security (GHS) index. Read more
Beware 'wellness' vapes. Despite claims that certain e-cigarette products may ease health problems, there's no proof that they do — and they may even cause health issues, the U.S. Food and Drug Administration warns. Read more
Related Posts
La investigación sobre el Alzheimer pone en duda la seguridad de unos populares complementos para el cerebro
MIÉRCOLES, 4 de mayo de 2022 (HealthDay News) -- Un complemento dietético que se...
Fetal Embolization Feasible for Vein of Galen Malformation
MONDAY, May 8, 2023 (HealthDay News) -- Transuterine ultrasound-guided fetal...
FDA Gives OK to Merck’s Antiviral At-Home COVID Pill
THURSDAY, Dec. 23, 2021 (HealthDay News) -- Many Americans now have two oral...
U.S. Orders 105 Million More Pfizer Shots for Fall Booster Campaign
THURSDAY, June 30, 2022 (HealthDay News) -- Anticipating a surge in booster...